grade dual AAV vectors
subretinal administrations of dual AAV vectors
dual AAV vector approach
Clinical trial of gene therapy
large MYO7A gene
fields of retinal gene therapy
innovative gene therapy approach
single combined subretinal administration of dual AAV vectors
development of gene therapy products
AAV cargo capacity
USHIB retinitis pigmentosa
clinical safety
large MYO7A expression cassette
retina of USHIB patients
manufacturing of clinical
MYO7A reconstitution
UshTher objective
multinational clinical trial
mouse model of USHIB
expression studies
blindness
UshTher success
humans
Usher syndrome type IB Usher syndrome
common combination of deafness
delivery of large genes
therapeutic efficacy
common conditions
ambitious objective
frequent forms of USH
bench
results
expertise
bedside
transfer
biodistribution
coordinator
good laboratory practices
SMEs
leaders
basis
Orphan Drug Designation
European Medicines Agency
competitive consortium
cochlear implants
halves
cure
time
packaging
mutations
planned activities
major limitations of
data
projects